Neurocutaneous Melanocytosis Registry

NCT04548817 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-09-30

No results posted yet for this study

Summary

This study will involve collecting information about the regular medical care you receive for large cutaneous melanocytic nevi (LCMN) or neurocutaneous melanocytosis (NCM).

Conditions

  • Cutaneous Melanocytic Neoplasm
  • Large Cutaneous Melanocytic Nevi
  • Neurocutaneous Melanocytosis

Sponsors & Collaborators

Principal Investigators

  • Yasmin Khakoo, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-03
Primary Completion
2027-09-03
Completion
2027-09-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04548817 on ClinicalTrials.gov